In the new filing, Lilly says it wants to wade into the legal proceedings to “protect its interests and help bring this suit to a swift end.” The company’s lawyers further contend that OFA ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

It won the Pulitzer Prize in 2020. Now comes a film version of the book, directed and written (with Joslyn Barnes) by Ross, whose only previous feature is the luminous 2018 documentary “Hale ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Enter: The Stanley Quencher H2.0 FlowState™ Tumbler (40 oz) and the Hydro Flask 40 oz Travel Tumbler. These two are the veritable "It Girls" of water bottle culture, so of course, I had to know ...

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.

Gary Cohn, a longtime journalist who won a Pulitzer Prize as a reporter for The Baltimore Sun, died Dec. 23 at 72 after collapsing at a Los Angeles-area bookstore following a boxing class.

While you might know Yeti for their top-of-the-line coolers, the brand also has a wide selection of great drinkware—including insulated tumblers and water bottles that are perfect for helping ...

Gary Cohn, 72, formerly of Philadelphia, an Inquirer alum who went on to win a Pulitzer Prize at the Baltimore Sun during a decades-long career devoted to investigative reporting, died Monday, Dec. 23 ...

Tech entrepreneur and Tesla (TSLA, Financials) CEO Elon Musk's disclosure of using weight-loss pharmaceuticalsincluding Eli Lilly's (LLY, Financials) Mounjaro and Novo Nordisk's Ozempichas drawn ...